Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: Evidence for an early, on-therapy biomarker of response

J. E. Stein, A. Soni, L. Danilova, T. R. Cottrell, T. F. Gajewski, F. S. Hodi, S. Bhatia, W. J. Urba, W. H. Sharfman, M. Wind-Rotolo, R. Edwards, E. J. Lipson, J. M. Taube

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: Evidence for an early, on-therapy biomarker of response'. Together they form a unique fingerprint.

Medicine & Life Sciences